Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sivan Cohen

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Frontiers in Immunology|February 28, 2025
A single point mutation on FLT3L-Fc protein increases the risk of immunogenicityDan Qin, Qui Phung, Patrick Wu, et al.
Cell Metabolism|April 15, 2016
AMPK Is Essential to Balance Glycolysis and Mitochondrial Metabolism to Control T-ALL Cell Stress and SurvivalRigel J Kishton, Carson E Barnes, Amanda G Nichols, et al.
Leukemia|January 10, 2022
A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myelomaSatoko Kakiuchi-Kiyota, Thorsten Ross, Heidi Ackerly Wallweber, et al.
Ebiomedicine|July 6, 2025
Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinationsJérémie Decalf, Evangeline Toy, Dongping He, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Frontiers in Immunology|February 28, 2025
A single point mutation on FLT3L-Fc protein increases the risk of immunogenicityDan Qin, Qui Phung, Patrick Wu, et al.
Cell Metabolism|April 15, 2016
AMPK Is Essential to Balance Glycolysis and Mitochondrial Metabolism to Control T-ALL Cell Stress and SurvivalRigel J Kishton, Carson E Barnes, Amanda G Nichols, et al.
Leukemia|January 10, 2022
A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myelomaSatoko Kakiuchi-Kiyota, Thorsten Ross, Heidi Ackerly Wallweber, et al.
Ebiomedicine|July 6, 2025
Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinationsJérémie Decalf, Evangeline Toy, Dongping He, et al.
Pageof 4